The Finasteride Plateau: Maintaining Gains When Progress Stalls

Finasteride results peak and stabilise. That plateau is the goal — maintained density, not perpetual improvement. Here is what to expect and how to read it.

The plateau is the expected destination of successful finasteride treatment, not a warning sign. Understanding what it represents — and how to distinguish it from slow progression — is part of managing the long-term treatment relationship.

When the plateau happens

Clinical trial data shows finasteride's hair density benefits develop progressively through approximately month 12, with some continued development through month 18. Beyond that, most users enter a stable maintenance phase: the improved density is preserved, but the improvements themselves are not continuing to accumulate. This plateau can last for years on continued treatment.

Why the plateau occurs

Finasteride suppresses DHT, which protects sensitive follicles from miniaturisation and allows follicles in early to moderate miniaturisation stages to recover. The recovery potential has a ceiling: follicles that have been dormant for many years or that have lost the dermal papilla's regenerative capacity cannot recover fully regardless of DHT suppression. Once the recoverable follicles have recovered, the remaining pattern reflects what is beyond recovery.

Maintaining the plateau

The plateau is maintained by continued daily finasteride. This is the critical point about long-term treatment: the benefit is not permanent by itself. Stopping finasteride allows DHT to return to baseline levels, which resumes miniaturisation in the protected follicles. The density gained over 12–18 months is progressively lost over 6–12 months after discontinuation.